Remove Pharma Remove Safety Remove Transportation
article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

80% provide transportation 1. 5 While the CDC gathers information on these topics for public health planning, there are immediate needs that pharma can address. . What Can Pharma Do? Pharma can help with caregiver-relevant labeling, training to perform nursing duties, and a multitude of other support services.

Pharma 98
article thumbnail

How one pharma “family business” places patients first

pharmaphorum

When people think about pharma, they often think about “big” pharma: large, faceless corporations. Every pharma company developing treatments for new diseases is contributing to some degree to better global health. But Giacomo Chiesi, head of Chiesi Global Rare Diseases, thinks of his 6,000-person company as a family business.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Challenges in the pharmaceutical supply chain Pharmaceutical supply chain issues include long transportation distances, low transparency of inventory levels and cargo theft. These can lead to inventory shortages, the paper noted. For instance, these drugs must be equipped with real-time insights. In conclusion, Kordestani et al.

article thumbnail

Cell and gene therapies: why advanced medicines call for specialised logistics

Pharmaceutical Technology

We pride ourselves on developing global transport solutions that mitigate risks and deliver real-time supply chain tracking and visibility. But getting these drugs to patients requires risky transportation, and safety and success hinges on reliable, temperature-controlled logistics.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. We note the Commission has not conducted an assessment on the impact of removing paper leaflets on patient safety. percent as EU average with some Member States as high as 25 percent).

article thumbnail

IMA: the all-in-one solutions provider for complete vaccines lines

European Pharmaceutical Review

A flexible attitude, together with careful and knowledgeable customisation, enables us to design innovative, automated lines that will process injectable products (eg, vaccines, oncology drugs) at high speeds and in total safety. MS260 Stretch banding machine (credit: IMA Pharma) For any type of case packing, you can find it with us.

Pharma 104
article thumbnail

Can the FDA keep the momentum going for rare disease drug approvals?

Pharmaceutical Technology

Amgen buying Horizon Therapeutics and Ipsen ’s acquisition of Albireo Pharma show an increased appetite for investment in therapies for rare diseases. The mutation leads to disordered thyroid hormone transport, which causes patients to experience intellectual and motor disabilities. This was not always the case. “Up compared to 38.5%

FDA 126